(Ms. Harsha Bangari,Managing Director,India Exim Bank,concludes USD 100 mn facility with Mr. Makoto Uchida, Managing Executive Officer, Global Head of Infrastructure and Environment Finance Group, Japan Bank for International Cooperation)
Export-Import Bank of India (India Exim Bank)concluded a USD 100 mn loan agreement with Japan Bank for International Cooperation(JBIC), along with three Japanese private financial institutions, namely, MUFG Bank, Ltd., the Bank of Kyoto, Ltd., and the Hachijuni Bank, Ltd., on May 23, 2022, on the side-lines of the Quad Leaders' Summit. The purpose of this facility is to support the Indian healthcare sector related to combating COVID-19, including but not limited to vaccine manufacturers, pharmaceutical companies, manufacturers of personal protective equipment, medical oxygen or other medical devices, hospitals, and other related activities.
As a prelude and to better understand the market requirements of this sector, India Exim Bank along with JBICorganised aRoundtable in collaboration with thePharmaceuticals Export Promotion Council of India (Pharmexcil) in July 2021, with participation fromthe CEOs of some of India’s largest healthcare and pharmaceutical companies. To further spread awareness on the funding structures available for such companies in India, India Exim Bankand JBIC jointly organised another programme in collaboration with Pharmexcilin September 2021.
Through this facility, India Exim Bank and JBIC will jointly work towards expanding safe and effectivemanufacturing of COVID-19 vaccines and related pharmaceutical and healthcare products in India.
India Exim Bank has been supporting the healthcare sector and all the segments in the pharmaceutical value chain. Apart from supporting domestic expansion projects of the companies in these sectors, the Bank has also supported the overseas endeavours of various Indian companies in the healthcare sector (including hospitals and healthcare facilities, pathological labs, and related training/ education services), pharmaceutical companies (including manufacturing of bulk drugs and formulations), and biosimilar/ biopharma (including life sciences) companies, among others. Additionally, India Exim Bank has been supporting research and development, new product development and other related areas.
India Exim Bank, established in 1982, is committed to promote India’s international trade and investment. The Bank offers Indian companies a comprehensive range of products and services, supported by analysis and research, with a view to enhancing their international competitiveness. The Bank actively supports Indian exporting companies, especially medium-sized enterprises, in their globalisation efforts through a variety of lending programmes.India Exim Bank has also been regularly innovating its products and services, keeping in view the dynamics of the global trade scenarios, for mutually beneficial engagements with partners across regions.
For further information, please contact
Mr. Tarun Sharma
Chief Financial Officer
Export-Import Bank of India
Centre One Building, Floor 21
World Trade Centre Complex Cuffe Parade